Felix Haglund and Magnus Carlsson discuss how Whole-Genome and Transcriptome Sequencing (WGTS) is transforming sarcoma diagnosis. Dr Haglund highlights findings from his recent study at Karolinska Hospital (PMID: 38573684), demonstrating WGTS´s superior diagnostic yield compared to standard-of-care tests. This comprehensive sequencing approach is now part of routine diagnostics for all sarcoma patients at Karolinska, enabling more precise and personalized care. Felix Haglund MD PhD is the Director of Bone and Soft Tissue Pathology and Consultant Clinical Pathologist at Karolinska University Hospital, Stockholm, Sweden. Magnus Carlsson is the former President of the Swedish Sarcoma Association, Stockholm, Sweden. Share this video in Swedish: https://youtu.be/FvDFSNSelx0 Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc #wholegenomesequencing #WGS #WTS #sarcoma #Illumina #ngs 00:00 Whole Genome Sequencing for Sarcomas 00:07 Sarcoma - a new study from Karolinska 01:42 Unexpected Insights from WGTS 02:35 WGTS Reclassified 10% of Sarcomas 03:03 WGTS can Reduce Misdiagnosis of Sarcomas 03:15 "The Correct Treatment Starts with the Correct Diagnosis" 04:03 Karolinska Institute Integrates WGTS into Routine Diagnostics Practice 05:17 How WGTS Alters the Patient's Journey 06:44 From Skepticism to Success: How WGTS Won Over Clinicians 09:01 Expanding Treatment Options for Rare Tumours Through Genetic Insights 09:01 A Researcher's Motivation to Uncover the Mysteries of Sarcoma